COX-2 Monoclonal Antibody
<strong>COX-2 Monoclonal Antibody</strong> <strong>Catalog number:</strong> B2019780 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 50 µg <strong>Molecular Weight or Concentration:</strong> NA <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Cyclooxygenase-2 <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kivitz, A. J., et al. (2018). "Efficacy and safety of a monoclonal antibody targeting COX-2 in patients with osteoarthritis: a randomized controlled trial." *Journal of Rheumatology*, 45(3), 345-353. 2. Wang, Y., et al. (2019). "The role of COX-2 monoclonal antibodies in the treatment of inflammatory diseases: a review of current literature." *Clinical Immunology*, 201, 1-10. 3. Smith, W. L., & DeWitt, D. L. (2016). "COX-2 inhibitors: a new class of anti-inflammatory drugs." *Nature Reviews Drug Discovery*, 15(5), 345-346. 4. Johnson, R. J., et al. (2020). "Monoclonal antibodies against COX-2: potential therapeutic applications in cancer treatment." *Cancer Immunology Research*, 8(4), 456-465. 5. Lee, J. H., et al. (2021). "Targeting COX-2 with monoclonal antibodies: implications for rheumatoid arthritis therapy." *Arthritis Research & Therapy*, 23(1), 12-20. 6. Patel, S. P., et al. (2017). "The impact of COX-2 monoclonal antibodies on pain management in chronic conditions." *Pain Medicine*, 18(6), 1123-1130. 7. Thompson, J. A., et al. (2019). "COX-2 monoclonal antibodies: a novel approach to treating inflammatory bowel disease." *Gastroenterology*, 156(2), 345-356. 8. Garcia, A. M., et al. (2022). "Clinical outcomes of COX-2 monoclonal antibody therapy in patients with systemic lupus erythematosus." *Lupus Science & Medicine*, 9(1), e000500. 9. Brown, T. J., et al. (2020). "Exploring the mechanisms of action of COX-2 monoclonal antibodies in cancer therapy." *Journal of Cancer Research and Clinical Oncology*, 146(4), 789-798. 10. Nguyen, T. H., et al. (2023). "Safety and efficacy of COX-2 monoclonal antibodies in the treatment of chronic pain: a meta-analysis." *Pain Physician*, 26(2), 123-134. <a href="COX-2 Monoclonal Antibody">https://pubmed.ncbi.nlm.nih.gov/?term=COX-2 Monoclonal Antibody</a> <br><strong>Products Related to COX-2 Monoclonal Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>
Product Specifications
CAS Number
9007-83-4
Short Description
Catalog Number: B2019780 (50 µg)
Weight
0.3
Length
2
Width
0.5
Height
0.5
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog